Skip to main content
. 2017 Apr 7;12(4):e0175280. doi: 10.1371/journal.pone.0175280

Fig 4. Kaplan–Meier curves of univariate analysis data (log–rank test).

Fig 4

(A, B) The RFS (A) and (B) OS of patients with high versus low MYL9 expression. (C) The OS for moderately/well-differentiated patients with high versus low MYL9 expression. (D) The OS for patients with T3+T4 classification with high versus low MYL9 expression. (E, F) The OS for patients without lymph node metastasis (E) and with lymph node metastasis (F) with high versus low MYL9 expression.